Trial Profile
OPTIMA HCN-1
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2009
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Acronyms OPTIMA HCN-1
- Sponsors Romark Laboratories
- 28 Feb 2009 Results reported at 19th Conference of the Asian Pacific Association for the Study of Liver Disease.
- 28 Feb 2009 New trial record.